Nexgel (NXGLW) Common Equity (2018 - 2026)

Nexgel (NXGLW) has reported Common Equity for 9 consecutive years, with $5.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 8.13% year-over-year to $5.5 million; the trailing twelve-month figure through Jun 2026 stood at $5.5 million (up 8.13% YoY), and the FY2025 full-year result was $4.9 million, down 19.56% from the prior year.
• Common Equity grew to $5.5 million in Q2 2026 per NXGLW's latest filing, from $4.9 million in the prior quarter.
• Across five years, Common Equity topped out at $10.3 million in Q1 2022 and bottomed at $4.5 million in Q2 2024.
• Historically, Common Equity has averaged $6.4 million across 5 years, with a median of $5.6 million in 2025.
• The widest YoY moves for Common Equity: up 3362.22% in 2022, down 36.81% in 2022.
• Over 5 years, Common Equity stood at $7.6 million in 2022, then sank by 32.36% to $5.2 million in 2023, then increased by 17.69% to $6.1 million in 2024, then fell by 19.56% to $4.9 million in 2025, then advanced by 11.76% to $5.5 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $5.5 million, $4.9 million, and $5.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.